nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—breast cancer	0.397	1	CbGaD
Hydroxychloroquine—CYP2D6—Idarubicin—breast cancer	0.0438	0.414	CbGbCtD
Hydroxychloroquine—CYP2D6—Vinorelbine—breast cancer	0.0214	0.202	CbGbCtD
Hydroxychloroquine—CYP2D6—Tamoxifen—breast cancer	0.0193	0.183	CbGbCtD
Hydroxychloroquine—CYP2D6—Vinblastine—breast cancer	0.0132	0.125	CbGbCtD
Hydroxychloroquine—CYP2D6—Doxorubicin—breast cancer	0.0081	0.0766	CbGbCtD
Hydroxychloroquine—Primaquine—KRT7—breast cancer	0.00249	0.209	CrCbGaD
Hydroxychloroquine—Primaquine—NQO2—breast cancer	0.00249	0.209	CrCbGaD
Hydroxychloroquine—Chloroquine—GSTA2—breast cancer	0.00109	0.0917	CrCbGaD
Hydroxychloroquine—Quinacrine—PLA2G4A—breast cancer	0.000945	0.0795	CrCbGaD
Hydroxychloroquine—Primaquine—CYP1B1—breast cancer	0.000842	0.0709	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1B1—breast cancer	0.000716	0.0603	CrCbGaD
Hydroxychloroquine—TLR7—uterus—breast cancer	0.000648	0.228	CbGeAlD
Hydroxychloroquine—TLR7—female reproductive system—breast cancer	0.000583	0.205	CbGeAlD
Hydroxychloroquine—TLR7—adrenal gland—breast cancer	0.000569	0.2	CbGeAlD
Hydroxychloroquine—TLR7—endocrine gland—breast cancer	0.000493	0.174	CbGeAlD
Hydroxychloroquine—Primaquine—CYP1A1—breast cancer	0.000455	0.0383	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1A1—breast cancer	0.000387	0.0326	CrCbGaD
Hydroxychloroquine—Chloroquine—TNF—breast cancer	0.000368	0.031	CrCbGaD
Hydroxychloroquine—TLR7—lymph node—breast cancer	0.000341	0.12	CbGeAlD
Hydroxychloroquine—Primaquine—CYP2D6—breast cancer	0.000338	0.0285	CrCbGaD
Hydroxychloroquine—Primaquine—CYP3A4—breast cancer	0.00029	0.0244	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP2D6—breast cancer	0.000288	0.0242	CrCbGaD
Hydroxychloroquine—Chloroquine—CYP1A1—breast cancer	0.00028	0.0235	CrCbGaD
Hydroxychloroquine—Chloroquine—CYP2D6—breast cancer	0.000208	0.0175	CrCbGaD
Hydroxychloroquine—Quinacrine—CYP3A4—breast cancer	0.000201	0.0169	CrCbGaD
Hydroxychloroquine—Chloroquine—CYP3A4—breast cancer	0.000178	0.015	CrCbGaD
Hydroxychloroquine—Quinacrine—ABCB1—breast cancer	0.000168	0.0141	CrCbGaD
Hydroxychloroquine—Chloroquine—ABCB1—breast cancer	0.000149	0.0125	CrCbGaD
Hydroxychloroquine—Body temperature increased—Fluorouracil—breast cancer	0.000107	0.000356	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—breast cancer	0.000107	0.000353	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—breast cancer	0.000106	0.000352	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Docetaxel—breast cancer	0.000106	0.00035	CcSEcCtD
Hydroxychloroquine—Weight decreased—Epirubicin—breast cancer	0.000105	0.000349	CcSEcCtD
Hydroxychloroquine—Vertigo—Capecitabine—breast cancer	0.000105	0.000346	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Irinotecan—breast cancer	0.000105	0.000346	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mitoxantrone—breast cancer	0.000105	0.000346	CcSEcCtD
Hydroxychloroquine—Vomiting—Thiotepa—breast cancer	0.000104	0.000346	CcSEcCtD
Hydroxychloroquine—Leukopenia—Capecitabine—breast cancer	0.000104	0.000345	CcSEcCtD
Hydroxychloroquine—Convulsion—Docetaxel—breast cancer	0.000104	0.000345	CcSEcCtD
Hydroxychloroquine—Drowsiness—Epirubicin—breast cancer	0.000104	0.000344	CcSEcCtD
Hydroxychloroquine—Rash—Thiotepa—breast cancer	0.000104	0.000343	CcSEcCtD
Hydroxychloroquine—Dermatitis—Thiotepa—breast cancer	0.000103	0.000343	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—breast cancer	0.000103	0.000343	CcSEcCtD
Hydroxychloroquine—Headache—Thiotepa—breast cancer	0.000103	0.000341	CcSEcCtD
Hydroxychloroquine—Somnolence—Paclitaxel—breast cancer	0.000103	0.000341	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000103	0.000341	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Capecitabine—breast cancer	0.000102	0.000339	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—breast cancer	0.000102	0.000339	CcSEcCtD
Hydroxychloroquine—Nausea—Vinorelbine—breast cancer	0.000102	0.000338	CcSEcCtD
Hydroxychloroquine—Asthenia—Mitoxantrone—breast cancer	0.000102	0.000337	CcSEcCtD
Hydroxychloroquine—Asthenia—Irinotecan—breast cancer	0.000102	0.000337	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000102	0.000337	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Paclitaxel—breast cancer	0.000101	0.000333	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Fluorouracil—breast cancer	0.0001	0.000332	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methotrexate—breast cancer	0.0001	0.000331	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Paclitaxel—breast cancer	9.99e-05	0.000331	CcSEcCtD
Hydroxychloroquine—Fatigue—Paclitaxel—breast cancer	9.97e-05	0.00033	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—breast cancer	9.95e-05	0.00033	CcSEcCtD
Hydroxychloroquine—Asthenia—Gemcitabine—breast cancer	9.91e-05	0.000328	CcSEcCtD
Hydroxychloroquine—Pain—Paclitaxel—breast cancer	9.89e-05	0.000328	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.84e-05	0.000326	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—breast cancer	9.82e-05	0.000325	CcSEcCtD
Hydroxychloroquine—Oedema—Docetaxel—breast cancer	9.81e-05	0.000325	CcSEcCtD
Hydroxychloroquine—Pruritus—Gemcitabine—breast cancer	9.78e-05	0.000324	CcSEcCtD
Hydroxychloroquine—Nausea—Thiotepa—breast cancer	9.76e-05	0.000323	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—breast cancer	9.74e-05	0.000323	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mitoxantrone—breast cancer	9.71e-05	0.000322	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Irinotecan—breast cancer	9.71e-05	0.000322	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—breast cancer	9.68e-05	0.000321	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Docetaxel—breast cancer	9.62e-05	0.000319	CcSEcCtD
Hydroxychloroquine—Pruritus—Fluorouracil—breast cancer	9.61e-05	0.000318	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Docetaxel—breast cancer	9.6e-05	0.000318	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—breast cancer	9.6e-05	0.000318	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—breast cancer	9.59e-05	0.000318	CcSEcCtD
Hydroxychloroquine—Skin disorder—Docetaxel—breast cancer	9.52e-05	0.000316	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	9.51e-05	0.000315	CcSEcCtD
Hydroxychloroquine—Oedema—Capecitabine—breast cancer	9.49e-05	0.000315	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Paclitaxel—breast cancer	9.46e-05	0.000313	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Gemcitabine—breast cancer	9.45e-05	0.000313	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—breast cancer	9.41e-05	0.000312	CcSEcCtD
Hydroxychloroquine—Dizziness—Irinotecan—breast cancer	9.38e-05	0.000311	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—breast cancer	9.36e-05	0.00031	CcSEcCtD
Hydroxychloroquine—Anorexia—Docetaxel—breast cancer	9.35e-05	0.00031	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Capecitabine—breast cancer	9.31e-05	0.000308	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—breast cancer	9.31e-05	0.000308	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—breast cancer	9.3e-05	0.000308	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Fluorouracil—breast cancer	9.3e-05	0.000308	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Capecitabine—breast cancer	9.3e-05	0.000308	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—breast cancer	9.28e-05	0.000307	CcSEcCtD
Hydroxychloroquine—Skin disorder—Capecitabine—breast cancer	9.22e-05	0.000306	CcSEcCtD
Hydroxychloroquine—Urticaria—Paclitaxel—breast cancer	9.19e-05	0.000304	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Paclitaxel—breast cancer	9.15e-05	0.000303	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Paclitaxel—breast cancer	9.15e-05	0.000303	CcSEcCtD
Hydroxychloroquine—Anorexia—Capecitabine—breast cancer	9.05e-05	0.0003	CcSEcCtD
Hydroxychloroquine—Vomiting—Mitoxantrone—breast cancer	9.02e-05	0.000299	CcSEcCtD
Hydroxychloroquine—Vomiting—Irinotecan—breast cancer	9.02e-05	0.000299	CcSEcCtD
Hydroxychloroquine—Dizziness—Fluorouracil—breast cancer	8.98e-05	0.000298	CcSEcCtD
Hydroxychloroquine—Visual impairment—Epirubicin—breast cancer	8.97e-05	0.000297	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—breast cancer	8.95e-05	0.000297	CcSEcCtD
Hydroxychloroquine—Rash—Mitoxantrone—breast cancer	8.94e-05	0.000296	CcSEcCtD
Hydroxychloroquine—Rash—Irinotecan—breast cancer	8.94e-05	0.000296	CcSEcCtD
Hydroxychloroquine—Dermatitis—Irinotecan—breast cancer	8.94e-05	0.000296	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mitoxantrone—breast cancer	8.94e-05	0.000296	CcSEcCtD
Hydroxychloroquine—Headache—Irinotecan—breast cancer	8.89e-05	0.000294	CcSEcCtD
Hydroxychloroquine—Headache—Mitoxantrone—breast cancer	8.89e-05	0.000294	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—breast cancer	8.8e-05	0.000292	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—breast cancer	8.79e-05	0.000291	CcSEcCtD
Hydroxychloroquine—Vomiting—Gemcitabine—breast cancer	8.79e-05	0.000291	CcSEcCtD
Hydroxychloroquine—Somnolence—Docetaxel—breast cancer	8.72e-05	0.000289	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—breast cancer	8.72e-05	0.000289	CcSEcCtD
Hydroxychloroquine—Rash—Gemcitabine—breast cancer	8.71e-05	0.000289	CcSEcCtD
Hydroxychloroquine—Dermatitis—Gemcitabine—breast cancer	8.7e-05	0.000288	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—breast cancer	8.7e-05	0.000288	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—breast cancer	8.68e-05	0.000288	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—breast cancer	8.66e-05	0.000287	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—breast cancer	8.66e-05	0.000287	CcSEcCtD
Hydroxychloroquine—Headache—Gemcitabine—breast cancer	8.66e-05	0.000287	CcSEcCtD
Hydroxychloroquine—Vomiting—Fluorouracil—breast cancer	8.64e-05	0.000286	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—breast cancer	8.61e-05	0.000285	CcSEcCtD
Hydroxychloroquine—Rash—Fluorouracil—breast cancer	8.57e-05	0.000284	CcSEcCtD
Hydroxychloroquine—Dermatitis—Fluorouracil—breast cancer	8.56e-05	0.000284	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Docetaxel—breast cancer	8.52e-05	0.000282	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Paclitaxel—breast cancer	8.52e-05	0.000282	CcSEcCtD
Hydroxychloroquine—Headache—Fluorouracil—breast cancer	8.51e-05	0.000282	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Docetaxel—breast cancer	8.47e-05	0.00028	CcSEcCtD
Hydroxychloroquine—Fatigue—Docetaxel—breast cancer	8.45e-05	0.00028	CcSEcCtD
Hydroxychloroquine—Nausea—Irinotecan—breast cancer	8.43e-05	0.000279	CcSEcCtD
Hydroxychloroquine—Nausea—Mitoxantrone—breast cancer	8.43e-05	0.000279	CcSEcCtD
Hydroxychloroquine—Pain—Docetaxel—breast cancer	8.39e-05	0.000278	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—breast cancer	8.3e-05	0.000275	CcSEcCtD
Hydroxychloroquine—Asthenia—Paclitaxel—breast cancer	8.3e-05	0.000275	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Capecitabine—breast cancer	8.25e-05	0.000273	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—breast cancer	8.23e-05	0.000273	CcSEcCtD
Hydroxychloroquine—Nausea—Gemcitabine—breast cancer	8.21e-05	0.000272	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Capecitabine—breast cancer	8.2e-05	0.000272	CcSEcCtD
Hydroxychloroquine—Fatigue—Capecitabine—breast cancer	8.19e-05	0.000271	CcSEcCtD
Hydroxychloroquine—Pruritus—Paclitaxel—breast cancer	8.19e-05	0.000271	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—breast cancer	8.16e-05	0.00027	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—breast cancer	8.16e-05	0.00027	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—breast cancer	8.14e-05	0.00027	CcSEcCtD
Hydroxychloroquine—Pain—Capecitabine—breast cancer	8.12e-05	0.000269	CcSEcCtD
Hydroxychloroquine—Malnutrition—Epirubicin—breast cancer	8.1e-05	0.000268	CcSEcCtD
Hydroxychloroquine—Nausea—Fluorouracil—breast cancer	8.07e-05	0.000267	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—breast cancer	8.05e-05	0.000267	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—breast cancer	8.03e-05	0.000266	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Docetaxel—breast cancer	8.02e-05	0.000266	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—breast cancer	8e-05	0.000265	CcSEcCtD
Hydroxychloroquine—Tension—Epirubicin—breast cancer	7.95e-05	0.000263	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Paclitaxel—breast cancer	7.92e-05	0.000262	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—breast cancer	7.87e-05	0.000261	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—breast cancer	7.78e-05	0.000258	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Capecitabine—breast cancer	7.76e-05	0.000257	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Docetaxel—breast cancer	7.75e-05	0.000257	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Docetaxel—breast cancer	7.75e-05	0.000257	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—breast cancer	7.75e-05	0.000257	CcSEcCtD
Hydroxychloroquine—Dizziness—Paclitaxel—breast cancer	7.65e-05	0.000253	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—breast cancer	7.64e-05	0.000253	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—breast cancer	7.61e-05	0.000252	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—breast cancer	7.55e-05	0.00025	CcSEcCtD
Hydroxychloroquine—Urticaria—Capecitabine—breast cancer	7.54e-05	0.00025	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Capecitabine—breast cancer	7.51e-05	0.000249	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Capecitabine—breast cancer	7.51e-05	0.000249	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—breast cancer	7.5e-05	0.000249	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—breast cancer	7.5e-05	0.000248	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—breast cancer	7.49e-05	0.000248	CcSEcCtD
Hydroxychloroquine—CYP2D6—female reproductive system—breast cancer	7.48e-05	0.0263	CbGeAlD
Hydroxychloroquine—Agitation—Epirubicin—breast cancer	7.45e-05	0.000247	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—breast cancer	7.36e-05	0.000244	CcSEcCtD
Hydroxychloroquine—Vomiting—Paclitaxel—breast cancer	7.36e-05	0.000244	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.32e-05	0.000243	CcSEcCtD
Hydroxychloroquine—Rash—Paclitaxel—breast cancer	7.29e-05	0.000242	CcSEcCtD
Hydroxychloroquine—Dermatitis—Paclitaxel—breast cancer	7.29e-05	0.000241	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—breast cancer	7.28e-05	0.000241	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—breast cancer	7.28e-05	0.000241	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—breast cancer	7.25e-05	0.00024	CcSEcCtD
Hydroxychloroquine—Headache—Paclitaxel—breast cancer	7.25e-05	0.00024	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Docetaxel—breast cancer	7.22e-05	0.000239	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Epirubicin—breast cancer	7.12e-05	0.000236	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—breast cancer	7.07e-05	0.000234	CcSEcCtD
Hydroxychloroquine—Asthenia—Docetaxel—breast cancer	7.04e-05	0.000233	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—breast cancer	7.02e-05	0.000233	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Capecitabine—breast cancer	6.99e-05	0.000232	CcSEcCtD
Hydroxychloroquine—Pruritus—Docetaxel—breast cancer	6.94e-05	0.00023	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—breast cancer	6.93e-05	0.00023	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—breast cancer	6.93e-05	0.00023	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—breast cancer	6.92e-05	0.000229	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—breast cancer	6.89e-05	0.000228	CcSEcCtD
Hydroxychloroquine—Nausea—Paclitaxel—breast cancer	6.87e-05	0.000228	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—breast cancer	6.87e-05	0.000227	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.85e-05	0.000227	CcSEcCtD
Hydroxychloroquine—Asthenia—Capecitabine—breast cancer	6.81e-05	0.000226	CcSEcCtD
Hydroxychloroquine—CYP2D6—female gonad—breast cancer	6.8e-05	0.024	CbGeAlD
Hydroxychloroquine—Vertigo—Doxorubicin—breast cancer	6.74e-05	0.000223	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—breast cancer	6.74e-05	0.000223	CcSEcCtD
Hydroxychloroquine—Pruritus—Capecitabine—breast cancer	6.72e-05	0.000223	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—breast cancer	6.71e-05	0.000222	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Docetaxel—breast cancer	6.71e-05	0.000222	CcSEcCtD
Hydroxychloroquine—Oedema—Epirubicin—breast cancer	6.61e-05	0.000219	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—breast cancer	6.59e-05	0.000218	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—breast cancer	6.5e-05	0.000215	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Capecitabine—breast cancer	6.5e-05	0.000215	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—breast cancer	6.49e-05	0.000215	CcSEcCtD
Hydroxychloroquine—Dizziness—Docetaxel—breast cancer	6.48e-05	0.000215	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—breast cancer	6.48e-05	0.000215	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—breast cancer	6.42e-05	0.000213	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.34e-05	0.00021	CcSEcCtD
Hydroxychloroquine—CYP2D6—endocrine gland—breast cancer	6.33e-05	0.0223	CbGeAlD
Hydroxychloroquine—Anorexia—Epirubicin—breast cancer	6.3e-05	0.000209	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—breast cancer	6.28e-05	0.000208	CcSEcCtD
Hydroxychloroquine—Dizziness—Capecitabine—breast cancer	6.28e-05	0.000208	CcSEcCtD
Hydroxychloroquine—Vomiting—Docetaxel—breast cancer	6.23e-05	0.000207	CcSEcCtD
Hydroxychloroquine—Rash—Docetaxel—breast cancer	6.18e-05	0.000205	CcSEcCtD
Hydroxychloroquine—Dermatitis—Docetaxel—breast cancer	6.18e-05	0.000205	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—breast cancer	6.14e-05	0.000204	CcSEcCtD
Hydroxychloroquine—Headache—Docetaxel—breast cancer	6.14e-05	0.000204	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—breast cancer	6.12e-05	0.000203	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—breast cancer	6.1e-05	0.000202	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—breast cancer	6.09e-05	0.000202	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—breast cancer	6.04e-05	0.0002	CcSEcCtD
Hydroxychloroquine—Vomiting—Capecitabine—breast cancer	6.04e-05	0.0002	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—breast cancer	6e-05	0.000199	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—breast cancer	5.99e-05	0.000199	CcSEcCtD
Hydroxychloroquine—Rash—Capecitabine—breast cancer	5.99e-05	0.000198	CcSEcCtD
Hydroxychloroquine—Dermatitis—Capecitabine—breast cancer	5.98e-05	0.000198	CcSEcCtD
Hydroxychloroquine—Headache—Capecitabine—breast cancer	5.95e-05	0.000197	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—breast cancer	5.94e-05	0.000197	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—breast cancer	5.88e-05	0.000195	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—breast cancer	5.83e-05	0.000193	CcSEcCtD
Hydroxychloroquine—Nausea—Docetaxel—breast cancer	5.82e-05	0.000193	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—breast cancer	5.78e-05	0.000191	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—breast cancer	5.77e-05	0.000319	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK8—breast cancer	5.77e-05	0.000319	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TCF7L2—breast cancer	5.75e-05	0.000318	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Epirubicin—breast cancer	5.75e-05	0.00019	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—breast cancer	5.73e-05	0.000317	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—breast cancer	5.71e-05	0.000189	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—breast cancer	5.7e-05	0.000189	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—NCOA1—breast cancer	5.68e-05	0.000314	CbGpPWpGaD
Hydroxychloroquine—Pain—Epirubicin—breast cancer	5.66e-05	0.000187	CcSEcCtD
Hydroxychloroquine—Nausea—Capecitabine—breast cancer	5.64e-05	0.000187	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—breast cancer	5.61e-05	0.000186	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP19A1—breast cancer	5.59e-05	0.000309	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Methotrexate—breast cancer	5.59e-05	0.000185	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—breast cancer	5.59e-05	0.000185	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH2—breast cancer	5.55e-05	0.000306	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HSP90AA1—breast cancer	5.55e-05	0.000306	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP19A1—breast cancer	5.52e-05	0.000305	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—SRC—breast cancer	5.47e-05	0.000302	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—breast cancer	5.44e-05	0.00018	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—breast cancer	5.41e-05	0.000179	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PRL—breast cancer	5.39e-05	0.000298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AGTR1—breast cancer	5.39e-05	0.000298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NFKBIA—breast cancer	5.36e-05	0.000296	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Doxorubicin—breast cancer	5.32e-05	0.000176	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—STK11—breast cancer	5.32e-05	0.000294	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADAM10—breast cancer	5.32e-05	0.000294	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—breast cancer	5.28e-05	0.000175	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—breast cancer	5.28e-05	0.000175	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—breast cancer	5.27e-05	0.000291	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PLG—breast cancer	5.26e-05	0.00029	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Epirubicin—breast cancer	5.25e-05	0.000174	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—BCL2—breast cancer	5.25e-05	0.00029	CbGpPWpGaD
Hydroxychloroquine—Pain—Doxorubicin—breast cancer	5.23e-05	0.000173	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—breast cancer	5.23e-05	0.000173	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—breast cancer	5.23e-05	0.000173	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methotrexate—breast cancer	5.21e-05	0.000173	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNG—breast cancer	5.2e-05	0.000287	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—COMT—breast cancer	5.2e-05	0.000287	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KIT—breast cancer	5.19e-05	0.000287	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—breast cancer	5.18e-05	0.000286	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MDM2—breast cancer	5.17e-05	0.000286	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF10—breast cancer	5.17e-05	0.000286	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RAF1—breast cancer	5.16e-05	0.000285	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RELA—breast cancer	5.13e-05	0.000284	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGF—breast cancer	5.13e-05	0.000284	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—COMT—breast cancer	5.13e-05	0.000283	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—breast cancer	5.1e-05	0.000282	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—breast cancer	5.1e-05	0.000282	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Methotrexate—breast cancer	5.07e-05	0.000168	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK3—breast cancer	5.04e-05	0.000279	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—breast cancer	5.03e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MTOR—breast cancer	5.03e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD4—breast cancer	5.02e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—breast cancer	5e-05	0.000166	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—breast cancer	5e-05	0.000166	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFA—breast cancer	4.99e-05	0.000276	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FOS—breast cancer	4.95e-05	0.000273	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFBR2—breast cancer	4.92e-05	0.000272	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—breast cancer	4.87e-05	0.000269	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—breast cancer	4.87e-05	0.000161	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—breast cancer	4.86e-05	0.000161	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ITPR1—breast cancer	4.84e-05	0.000267	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Doxorubicin—breast cancer	4.84e-05	0.00016	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—breast cancer	4.84e-05	0.00016	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methotrexate—breast cancer	4.84e-05	0.00016	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CASP8—breast cancer	4.84e-05	0.000267	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP3—breast cancer	4.81e-05	0.000266	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT5A—breast cancer	4.81e-05	0.000266	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB4—breast cancer	4.81e-05	0.000266	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—breast cancer	4.8e-05	0.000265	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—breast cancer	4.78e-05	0.000264	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—breast cancer	4.76e-05	0.000263	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT2—breast cancer	4.75e-05	0.000262	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—breast cancer	4.75e-05	0.000157	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—breast cancer	4.72e-05	0.000261	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	4.69e-05	0.000259	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—breast cancer	4.68e-05	0.000155	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—breast cancer	4.67e-05	0.000155	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—breast cancer	4.66e-05	0.000258	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SMAD4—breast cancer	4.66e-05	0.000257	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—breast cancer	4.64e-05	0.000256	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1R—breast cancer	4.63e-05	0.000256	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—breast cancer	4.62e-05	0.000255	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—breast cancer	4.56e-05	0.000252	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HES1—breast cancer	4.55e-05	0.000251	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—breast cancer	4.53e-05	0.00025	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—breast cancer	4.53e-05	0.00015	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NCOR1—breast cancer	4.52e-05	0.00025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PLA2G4A—breast cancer	4.52e-05	0.00025	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—breast cancer	4.51e-05	0.000149	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A1—breast cancer	4.51e-05	0.000249	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—JUN—breast cancer	4.5e-05	0.000248	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Methotrexate—breast cancer	4.49e-05	0.000149	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF1—breast cancer	4.47e-05	0.000247	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CSF2—breast cancer	4.47e-05	0.000247	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—breast cancer	4.46e-05	0.000247	CbGpPWpGaD
Hydroxychloroquine—Rash—Methotrexate—breast cancer	4.46e-05	0.000148	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—breast cancer	4.45e-05	0.000147	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	4.45e-05	0.000246	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRG1—breast cancer	4.44e-05	0.000245	CbGpPWpGaD
Hydroxychloroquine—Headache—Methotrexate—breast cancer	4.43e-05	0.000147	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—H2AFX—breast cancer	4.41e-05	0.000243	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—breast cancer	4.39e-05	0.000145	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—E2F1—breast cancer	4.37e-05	0.000242	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Epirubicin—breast cancer	4.37e-05	0.000145	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CDKN1A—breast cancer	4.36e-05	0.000241	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTEN—breast cancer	4.35e-05	0.00024	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—breast cancer	4.33e-05	0.000143	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—breast cancer	4.3e-05	0.000238	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK8—breast cancer	4.25e-05	0.000235	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—breast cancer	4.21e-05	0.000139	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SPP1—breast cancer	4.2e-05	0.000232	CbGpPWpGaD
Hydroxychloroquine—Nausea—Methotrexate—breast cancer	4.2e-05	0.000139	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—breast cancer	4.19e-05	0.000139	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—breast cancer	4.17e-05	0.000138	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—breast cancer	4.17e-05	0.000138	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—breast cancer	4.16e-05	0.00023	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB3—breast cancer	4.16e-05	0.00023	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR2—breast cancer	4.15e-05	0.000229	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2—breast cancer	4.15e-05	0.000229	CbGpPWpGaD
Hydroxychloroquine—Headache—Epirubicin—breast cancer	4.14e-05	0.000137	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNG—breast cancer	4.11e-05	0.000227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MDM2—breast cancer	4.09e-05	0.000226	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RAF1—breast cancer	4.07e-05	0.000225	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RELA—breast cancer	4.06e-05	0.000224	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—breast cancer	4.05e-05	0.000134	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—SRC—breast cancer	4.03e-05	0.000223	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—breast cancer	4.03e-05	0.000223	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—breast cancer	3.98e-05	0.00022	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—breast cancer	3.98e-05	0.00022	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MTOR—breast cancer	3.98e-05	0.00022	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD4—breast cancer	3.97e-05	0.000219	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—breast cancer	3.93e-05	0.00013	CcSEcCtD
Hydroxychloroquine—Vomiting—Doxorubicin—breast cancer	3.89e-05	0.000129	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—STAT3—breast cancer	3.89e-05	0.000215	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR1—breast cancer	3.87e-05	0.000214	CbGpPWpGaD
Hydroxychloroquine—Rash—Doxorubicin—breast cancer	3.86e-05	0.000128	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—breast cancer	3.86e-05	0.000128	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—breast cancer	3.85e-05	0.000213	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—breast cancer	3.83e-05	0.000127	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HIF1A—breast cancer	3.81e-05	0.000211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—breast cancer	3.73e-05	0.000206	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—breast cancer	3.72e-05	0.000205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK3—breast cancer	3.72e-05	0.000205	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—breast cancer	3.69e-05	0.000204	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CAV1—breast cancer	3.69e-05	0.000204	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—breast cancer	3.67e-05	0.000203	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—breast cancer	3.65e-05	0.000202	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—breast cancer	3.64e-05	0.000201	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—breast cancer	3.64e-05	0.00012	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metabolism—SYNJ2—breast cancer	3.63e-05	0.0002	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JUN—breast cancer	3.55e-05	0.000196	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—breast cancer	3.55e-05	0.000196	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—breast cancer	3.54e-05	0.000195	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—breast cancer	3.53e-05	0.000195	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FN1—breast cancer	3.51e-05	0.000194	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NFKBIA—breast cancer	3.47e-05	0.000191	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1A—breast cancer	3.45e-05	0.00019	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—breast cancer	3.44e-05	0.00019	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH1—breast cancer	3.43e-05	0.00019	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—breast cancer	3.4e-05	0.000188	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NDUFS3—breast cancer	3.37e-05	0.000186	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK8—breast cancer	3.36e-05	0.000186	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—breast cancer	3.36e-05	0.000185	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KIT—breast cancer	3.36e-05	0.000185	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—breast cancer	3.36e-05	0.000185	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—breast cancer	3.34e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGF—breast cancer	3.32e-05	0.000183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SRC—breast cancer	3.19e-05	0.000176	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CHST9—breast cancer	3.17e-05	0.000175	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BRAF—breast cancer	3.16e-05	0.000174	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—breast cancer	3.07e-05	0.00017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1—breast cancer	3.07e-05	0.00017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT2—breast cancer	3.07e-05	0.00017	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—breast cancer	3.07e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—COX11—breast cancer	3.01e-05	0.000166	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—breast cancer	2.95e-05	0.000163	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK3—breast cancer	2.94e-05	0.000162	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SERPINE1—breast cancer	2.92e-05	0.000161	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—breast cancer	2.84e-05	0.000157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—breast cancer	2.79e-05	0.000154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOS3—breast cancer	2.79e-05	0.000154	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CDA—breast cancer	2.75e-05	0.000152	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SHMT1—breast cancer	2.75e-05	0.000152	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—breast cancer	2.72e-05	0.00015	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A5—breast cancer	2.65e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLCO1B1—breast cancer	2.65e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MDM2—breast cancer	2.64e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—breast cancer	2.64e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RAF1—breast cancer	2.63e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RELA—breast cancer	2.62e-05	0.000145	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—breast cancer	2.61e-05	0.000144	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MTOR—breast cancer	2.57e-05	0.000142	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—breast cancer	2.57e-05	0.000142	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APRT—breast cancer	2.56e-05	0.000141	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—breast cancer	2.51e-05	0.000138	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—breast cancer	2.47e-05	0.000137	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—breast cancer	2.43e-05	0.000134	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—breast cancer	2.41e-05	0.000133	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ESRRA—breast cancer	2.4e-05	0.000133	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ANGPTL4—breast cancer	2.4e-05	0.000133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—breast cancer	2.37e-05	0.000131	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—breast cancer	2.36e-05	0.000131	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—breast cancer	2.3e-05	0.000127	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JUN—breast cancer	2.3e-05	0.000127	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—breast cancer	2.28e-05	0.000126	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HADHB—breast cancer	2.28e-05	0.000126	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPI—breast cancer	2.28e-05	0.000126	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—breast cancer	2.24e-05	0.000124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—breast cancer	2.24e-05	0.000124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1A—breast cancer	2.23e-05	0.000123	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—breast cancer	2.22e-05	0.000123	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK8—breast cancer	2.17e-05	0.00012	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDH1A1—breast cancer	2.17e-05	0.00012	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDH7A1—breast cancer	2.17e-05	0.00012	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—breast cancer	2.15e-05	0.000119	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UMPS—breast cancer	2.08e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FHL2—breast cancer	2.08e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ADSL—breast cancer	2.08e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PHGDH—breast cancer	2.08e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NME1—breast cancer	2.08e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SRC—breast cancer	2.06e-05	0.000114	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LDHB—breast cancer	2.04e-05	0.000113	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BRIP1—breast cancer	2.04e-05	0.000113	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HPSE—breast cancer	2.04e-05	0.000113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—breast cancer	2.01e-05	0.000111	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—breast cancer	1.99e-05	0.00011	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—breast cancer	1.98e-05	0.000109	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA3—breast cancer	1.94e-05	0.000107	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCC1—breast cancer	1.94e-05	0.000107	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMMR—breast cancer	1.94e-05	0.000107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK3—breast cancer	1.9e-05	0.000105	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.88e-05	0.000104	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—breast cancer	1.85e-05	0.000102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—breast cancer	1.84e-05	0.000102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—breast cancer	1.81e-05	9.98e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA4—breast cancer	1.77e-05	9.79e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA9—breast cancer	1.77e-05	9.79e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPX2—breast cancer	1.73e-05	9.54e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA2—breast cancer	1.73e-05	9.54e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—breast cancer	1.71e-05	9.43e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPX4—breast cancer	1.71e-05	9.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SULT1A1—breast cancer	1.71e-05	9.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA1—breast cancer	1.67e-05	9.2e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—IDH1—breast cancer	1.67e-05	9.2e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAT2—breast cancer	1.65e-05	9.1e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—breast cancer	1.57e-05	8.66e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—breast cancer	1.52e-05	8.38e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—breast cancer	1.45e-05	8.01e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—DPYD—breast cancer	1.44e-05	7.98e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MED12—breast cancer	1.44e-05	7.98e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDOA—breast cancer	1.42e-05	7.85e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—breast cancer	1.39e-05	7.67e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA3—breast cancer	1.38e-05	7.62e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A2—breast cancer	1.37e-05	7.57e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTR—breast cancer	1.34e-05	7.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CPT1A—breast cancer	1.34e-05	7.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCG2—breast cancer	1.34e-05	7.42e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HPGDS—breast cancer	1.32e-05	7.27e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HBA1—breast cancer	1.31e-05	7.23e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—breast cancer	1.28e-05	7.08e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACHE—breast cancer	1.28e-05	7.05e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—breast cancer	1.28e-05	7.05e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP17A1—breast cancer	1.21e-05	6.68e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS1—breast cancer	1.2e-05	6.61e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ENO1—breast cancer	1.2e-05	6.61e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA2—breast cancer	1.15e-05	6.36e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FASN—breast cancer	1.12e-05	6.17e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BCHE—breast cancer	1.11e-05	6.14e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC5A5—breast cancer	1.1e-05	6.07e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NQO1—breast cancer	1.06e-05	5.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A1—breast cancer	1.06e-05	5.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP3A4—breast cancer	1.03e-05	5.72e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1B1—breast cancer	1.02e-05	5.62e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSP90AA1—breast cancer	9.98e-06	5.51e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA1—breast cancer	9.71e-06	5.36e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—STK11—breast cancer	9.57e-06	5.28e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP19A1—breast cancer	9.57e-06	5.28e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—COMT—breast cancer	8.89e-06	4.91e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—breast cancer	8.85e-06	4.89e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMOX1—breast cancer	8.73e-06	4.82e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ITPR1—breast cancer	8.71e-06	4.81e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—breast cancer	8.38e-06	4.63e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMS—breast cancer	8.23e-06	4.55e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLA2G4A—breast cancer	8.13e-06	4.49e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOR1—breast cancer	8.13e-06	4.49e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—breast cancer	8.13e-06	4.49e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPX1—breast cancer	7.79e-06	4.3e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A1—breast cancer	7.71e-06	4.26e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ERCC2—breast cancer	7.65e-06	4.22e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—breast cancer	7.19e-06	3.97e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAV1—breast cancer	6.63e-06	3.66e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—breast cancer	6.04e-06	3.34e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—breast cancer	5.31e-06	2.93e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—breast cancer	5.24e-06	2.9e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NOS3—breast cancer	5.01e-06	2.77e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—breast cancer	4.63e-06	2.56e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—breast cancer	4.59e-06	2.53e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—breast cancer	4e-06	2.21e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—breast cancer	2.82e-06	1.56e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—breast cancer	2.3e-06	1.27e-05	CbGpPWpGaD
